Richard J. Napolitano - 01 Feb 2023 Form 4 Insider Report for Teladoc Health, Inc. (TDOC)

Role: CHIEF ACCOUNTING OFFICER
Signature: /s/ Adam C. Vandervoort, Attorney-in-Fact
Issuer symbol: TDOC
Transactions as of: 01 Feb 2023
Net transactions value: -$25,973
Form type: 4
Filing time: 03 Feb 2023, 15:09:26 UTC
Previous filing: 26 Sep 2022
Next filing: 03 Mar 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TDOC	Common Stock	Options Exercise		+2,019	+128%		3,595	01 Feb 2023	Direct	F1
transaction	TDOC	Common Stock	Sale	$25,973	-787	-22%	$33.00	2,808	02 Feb 2023	Direct	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	TDOC	Restricted Stock Units	Options Exercise	$0	-2,019	-50%	$0.000000	2,020	01 Feb 2023	Common Stock	2,019		Direct	F1, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
F2	Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit awards.
F3	On February 1, 2021, the reporting person was granted 6,058 restricted stock units, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date.